Inhibitory Antibodies
-
F2041 Anti-FGFR2/CD332 Antibody (Aprutumab)Summary: Anti-FGFR2/CD332 Antibody (Aprutumab) -
F2042 Anti-FGFR2/CD332 Antibody (Bemarituzumab)Summary: Anti-FGFR2/CD332 Antibody (Bemarituzumab) -
F2043 Anti-FGFR3/CD333 Antibody (Vofatamab)Summary: Anti-FGFR3/CD333 Antibody (Vofatamab) -
F2044 Anti-VEGFR2/KDR/CD309 Antibody (Olinvacimab)Summary: Anti-VEGFR2/KDR/CD309 Antibody (Olinvacimab) -
F2045 Anti-VEGF Antibody (Bevacizumab)Summary: Anti-VEGF Antibody (Bevacizumab) -
F2046 Anti-VEGFR2/KDR/CD309 Antibody (Ramucirumab)Summary: Anti-VEGFR2/KDR/CD309 Antibody (Ramucirumab) -
F2047 Anti-IGF1R/CD221 Antibody (Dalotuzumab)Summary: Anti-IGF1R/CD221 Antibody (Dalotuzumab) -
F2048 Anti-CSF2/GM-CSF Antibody (Gimsilumab)Summary: Anti-CSF2/GM-CSF Antibody (Gimsilumab) -
F2049 Anti-CSF2Ra/GM-CSFRa/CD116 Antibody (Mavrilimumab)Summary: Anti-CSF2Ra/GM-CSFRa/CD116 Antibody (Mavrilimumab) -
F2050 Anti-CSF1/M-CSF Antibody (Lacnotuzumab)Summary: Anti-CSF1/M-CSF Antibody (Lacnotuzumab)